A systematic review on mutation markers for bladder cancer diagnosis in urine

OBJECTIVES: To systematically summarise the available evidence on urinary bladder cancer (BC) mutation markers. Gene mutations are expected to provide novel biomarkers for urinary BC diagnosis. To date, evidence on urinary BC mutation markers has not proven sufficient to be adopted by clinical guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Hentschel, Anouk E., van der Toom, Emma E., Vis, André N., Ket, Johannes C.F., Bosschieter, Judith, Heymans, Martijn W., van Moorselaar, R. Jeroen A., Steenbergen, Renske D.M., Nieuwenhuijzen, Jakko A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818192/
https://www.ncbi.nlm.nih.gov/pubmed/32539176
http://dx.doi.org/10.1111/bju.15137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818192/
https://www.ncbi.nlm.nih.gov/pubmed/32539176
http://dx.doi.org/10.1111/bju.15137

Ejemplares similares